Status:
COMPLETED
Prognostic Factors Affecting Survival of Gastric GIST
Lead Sponsor:
Université de Sousse
Conditions:
Gastric GIST
Eligibility:
All Genders
10-90 years
Brief Summary
Gastrointestinal stromal tumor (GIST) is the most common non-epithelial mesenchymal tumor of the gastrointestinal tract. Surgical treatment is the only curative therapy for primary localized GIST. Thi...
Detailed Description
The prognosis of gastric GIST depends on various tumor factors with the most important being the mitotic index and tumor necrosis. Imatinib therapy has revolutionized the treatment of advanced GIST. ...
Eligibility Criteria
Inclusion
- patient having gastric GIST
- \-
Exclusion
- patient operated for other gastric tumors
Key Trial Info
Start Date :
January 1 2000
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 2 2018
Estimated Enrollment :
34 Patients enrolled
Trial Details
Trial ID
NCT04269941
Start Date
January 1 2000
End Date
January 2 2018
Last Update
February 17 2020
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.